Minor grove binding ligands disrupt PARP-1 activation pathways.

Minor grove binding ligands disrupt PARP-1 activation pathways.

Item
http://www.wikidata.org/entity/Q37660306
Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivoPiperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma.LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma.A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy.Inhibition of Poly(ADP-Ribose) Polymerase by Nucleic Acid Metabolite 7-Methylguanine.PARP-1 Interaction with and Activation by Histones and Nucleosomes.The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma.The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors.
P2860

Minor grove binding ligands disrupt PARP-1 activation pathways.

Item
http://www.wikidata.org/entity/Q37660306
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minor grove binding ligands disrupt PARP-1 activation pathways.
@en
Minor grove binding ligands disrupt PARP-1 activation pathways.
@nl
type
label
Minor grove binding ligands disrupt PARP-1 activation pathways.
@en
Minor grove binding ligands disrupt PARP-1 activation pathways.
@nl
prefLabel
Minor grove binding ligands disrupt PARP-1 activation pathways.
@en
Minor grove binding ligands disrupt PARP-1 activation pathways.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Minor grove binding ligands disrupt PARP-1 activation pathways
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932